AptaBio Therapeutics Inc. (KOSDAQ:293780)
7,830.00
-150.00 (-1.88%)
Jun 5, 2025, 3:30 PM KST
AptaBio Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 |
---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 18,918 | 25,542 | 25,016 | 1,989 |
Short-Term Investments | 1,020 | 1,020 | 19,000 | 15,026 |
Trading Asset Securities | 4,988 | 4,954 | 8,869 | - |
Cash & Short-Term Investments | 24,925 | 31,515 | 52,885 | 17,015 |
Cash Growth | -50.22% | -40.41% | 210.81% | - |
Accounts Receivable | 982.9 | 893.71 | - | - |
Other Receivables | 207.49 | 238.05 | 366.31 | 224.46 |
Receivables | 1,494 | 1,435 | 2,659 | 3,047 |
Inventory | 184.54 | 224.87 | - | - |
Prepaid Expenses | 62.61 | 212.04 | 176.31 | 88.23 |
Other Current Assets | 2,758 | 1,548 | 1,754 | 268.93 |
Total Current Assets | 29,424 | 34,935 | 57,474 | 20,419 |
Property, Plant & Equipment | 6,073 | 4,962 | 5,129 | 5,848 |
Long-Term Investments | 31,092 | 30,986 | 23,779 | 27,885 |
Other Intangible Assets | 34.27 | 39.35 | 61.09 | 37.83 |
Other Long-Term Assets | 2,408 | 3,611 | 3,675 | 1,924 |
Total Assets | 71,931 | 77,434 | 92,519 | 56,114 |
Accounts Payable | 127.07 | 1.87 | - | - |
Accrued Expenses | 414.53 | 609.79 | 337.19 | 455.54 |
Short-Term Debt | 7,727 | 7,244 | - | - |
Current Portion of Leases | 126.4 | 154.6 | 131.08 | 109.73 |
Current Income Taxes Payable | - | - | 1.48 | - |
Other Current Liabilities | 8,010 | 11,529 | 348.2 | 474.75 |
Total Current Liabilities | 16,405 | 19,540 | 817.95 | 1,040 |
Long-Term Debt | - | - | 13,569 | - |
Long-Term Leases | 115.91 | 122.01 | 233.45 | 256.3 |
Other Long-Term Liabilities | 77.44 | 71.4 | 13,524 | 54.58 |
Total Liabilities | 20,198 | 23,237 | 31,156 | 3,744 |
Common Stock | 13,441 | 13,441 | 11,149 | 11,149 |
Additional Paid-In Capital | 149,733 | 149,733 | 129,712 | 109,025 |
Retained Earnings | -112,691 | -110,112 | -80,713 | -68,473 |
Comprehensive Income & Other | 1,250 | 1,135 | 696.37 | 668.63 |
Total Common Equity | 51,732 | 54,197 | 60,845 | 52,370 |
Shareholders' Equity | 51,732 | 54,197 | 61,363 | 52,370 |
Total Liabilities & Equity | 71,931 | 77,434 | 92,519 | 56,114 |
Total Debt | 7,969 | 7,521 | 13,934 | 366.03 |
Net Cash (Debt) | 16,956 | 23,994 | 38,951 | 16,649 |
Net Cash Growth | -51.92% | -38.40% | 133.95% | - |
Net Cash Per Share | 703.69 | 1019.11 | 1746.78 | 746.98 |
Filing Date Shares Outstanding | 26.88 | 26.88 | 22.3 | 22.3 |
Total Common Shares Outstanding | 26.88 | 26.88 | 23.34 | 22.3 |
Working Capital | 13,019 | 15,395 | 56,656 | 19,379 |
Book Value Per Share | 1924.47 | 2016.16 | 2607.28 | 2348.53 |
Tangible Book Value | 51,698 | 54,158 | 60,784 | 52,332 |
Tangible Book Value Per Share | 1923.19 | 2014.69 | 2604.66 | 2346.83 |
Land | 2,115 | 1,787 | 1,787 | 1,922 |
Buildings | 4,111 | 3,215 | 3,046 | 3,388 |
Machinery | 1,305 | 1,268 | 1,196 | 1,101 |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.